The FDA brings strict instructions to Endo Pharmaceuticals for turning down Opana ER, Now, more Opioid based painkillers are likely to be pulled off from the market soon.
The FDA recently announced a nationwide recall for a certain contraceptive pill which has reportedly been packed wrongly.
Insurance companies want the practice of money back guarantees for prescription drugs to catch on. The major talking point coming out of it, is if that policy really wants to benefit consumers.
Codeine and Tramadol are pain relievers. Just recently, the FDA stated that its not safe to give or prescribe these for kids.
Ocrevus antibody for the treatment of Relapsing-Remitting Multiple Sclerosis (RMS). Patient taking partin the clinical trial shares that she's feeling great again with the ocrelizumab infusion.
The FDA has approved the sale and marketing of a genetic test for disease risk called the Personal Genome Service Genetic Health Risk from the company 23andME.
The US Senate will discuss the nomination of Dr. Scott Gottlieb to the Food and Drug Administration but Democrats believe he is not fit for the job as he is deemed too close to the pharmaceutical industry.
People suffering from severe eczema can finally have their treatment. It does however, come with a huge price tag.
Weight-loss products dazzle consumers by claiming to eliminate excess body fat by simply taking pills or special drinks. Some pills really work and curb a person's appetite, but not all of them can do this.
The US Food and Drug Authority has recently announced the approval of the first treatment for nocturnal polyuria.
There is no cure for Duschenne muscular dystrophy. Patients' life expectancy is usually 20 to 30 years. Symptons commonly begin between ages three and five, and boy boys are affected much more than girls.
There have been no reported illnesses or injuries caused by the recalled product. Consumers may exchange or get a full refund from PetSmart stores.
Belladonna is commonly known as deadly nightshade, which is a toxic substance. FDA laboratory assessment of Hyland's homeopahtic teething products confirmed on Friday inconsistent amounts of belladonna.
Genentech, member of Roche's company has found positive results for Phase III of their GiACTA study. FDA granted priority review to ensure that Actemra can be made safe and available for patients with giant cell arteritis.
The U.S. Food and Drug Administration (FDA) approves the first drug intended to treat Marginal Zone Lymphoma (MZL).
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.